H

Researcher Profile

H.Y. Lim

3

Publications

370

Citations

10

Co-Authors

3

Active Years

Publications

Open Access Journal Article Annals of Oncology Jun 01, 2024

Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040

I. Melero · T. Yau · Y.-K. Kang · T.-Y. Kim +17 more

10.1016/j.annonc.2024.03.005 77 citations

Open Access Journal Article Annals of Oncology Jun 01, 2018

Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma

G.K. Abou-Alfa · S. Qin · B.-Y. Ryoo · S.-N. Lu +23 more

10.1093/annonc/mdy101 184 citations

Open Access Journal Article Annals of Oncology Jun 01, 2013

A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma

A.C. Roy · S.R. Park · D. Cunningham · Y.K. Kang +10 more

10.1093/annonc/mdt002 109 citations

Publication Timeline

2024

1

2018

1

2013

1

Frequent Co-Authors